I

ImmuneOncia Therapeutics Inc.

21 employees

Immuneoncia Therapeutics is an immuno-oncology-centric biopharmaceutical company.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
immuno-oncology
Medical
Pharmaceutical
oncology
Biopharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$40M

from 2 investors over 2 rounds

I

ImmuneOncia Therapeutics Inc. raised $20M on January 17, 2022

Investors: Premier Partners

I

ImmuneOncia Therapeutics Inc. raised $40M on February 12, 2019

Investors: Paratus Investment Inc.

FAQ